Review
Published on 21 May 2025
Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1514994
- 7,097 views
- 6 citations



